Skip to main content
logo
AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.3269
+0.0369 (12.72%)
Sep 11, 2026, 4:00 PM EDT - Market closed

AEON Biopharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-19.9-16.3-27.82-52.84-48.43-36.88
Net Income
-54.62-39.2242.01-384.63-52.56-55.64
Earnings Per Share
-1.89-3.9572.93-4.99-27.25-31.73
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3.433.010.015.169.755.13
Total Debt
2.7835.7512.960.28131.7986.89
Net Cash (Debt)
0.66-32.74-12.944.88-122.05-81.76
Net Cash Growth
------
Net Cash Per Share
0.02-3.30-22.470.06-63.29-46.63

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-13.64-17.31-20.29-47.83-35.58-28.43
Capital Expenditures
--0---0.31-0.17
Free Cash Flow
-13.64-17.31-20.29-47.83-35.89-28.6
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--0.51---